CVSI - CV Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
4.1570
-0.0230 (-0.55%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close4.1800
Open4.1900
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range4.1100 - 4.2250
52 Week Range1.5200 - 9.2000
Volume290,934
Avg. Volume905,550
Market Cap416.669M
Beta (3Y Monthly)-0.24
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 5 Small-Cap Pot Stocks With Rising Profit Projections
    Motley Fool10 days ago

    5 Small-Cap Pot Stocks With Rising Profit Projections

    North American cannabis supply issues haven't been a problem for these marijuana stocks.

  • CBD leader CV Sciences jumps 10% on Kroger deal to sell CBD oil in 17 US states
    Yahoo Finance12 days ago

    CBD leader CV Sciences jumps 10% on Kroger deal to sell CBD oil in 17 US states

    Shares of CBD company CV Sciences jumped 10% on a deal with retailer Kroger to sell its oils in nearly 1,000 stores.

  • Barrons.com21 days ago

    Cannabis Legalization Has Taken a Couple of Big Steps Forward

    Illinois became the first state to approve approved recreational marijuana use for adults by legislature, as opposed to a voter referendum.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of CVSI earnings conference call or presentation 8-May-19 8:30pm GMT

    Q1 2019 CV Sciences Inc Earnings Call

  • CV Sciences, Inc. (CVSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks2 months ago

    CV Sciences, Inc. (CVSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    CV Sciences, Inc. (CVSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Benzinga2 months ago

    Canadian Investors Can Light Up A New Cannabis ETF Focused On US Companies

    Horizons is the company behind the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ)(OTC: HMLSF), which is one of the world's largest cannabis ETFs. “HMUS will be the first ETF in the world that is solely focused on providing exposure to companies with significant business activities in, or significant exposure to, the United States marijuana or hemp industries,” according to a statement.

  • 3 Best Marijuana Stocks in March: Are They Buys Now?
    Motley Fool3 months ago

    3 Best Marijuana Stocks in March: Are They Buys Now?

    Spring forward in March? These three marijuana stocks did a lot more than that.

  • Benzinga3 months ago

    CV Sciences Skewing Successfully Thanks To CBD Sales

    Earlier this month, CV Sciences Inc (OTCMKTS: CVSI) released their financial results for the fiscal year ending on Dec. 31, 2018, posting record growth in both revenue and retail distribution. Indeed, CV Sciences finished out the fiscal year with a particularly strong fourth quarter. One of CV Sciences most popular product lines is PlusCBD Gold, which contains high concentrations of CBD instead of a mixture of CBD, CBDA, and other hemp-derived cannabinoids.

  • Benzinga4 months ago

    US Hemp Authority Issues First 13 Certification Seals

    The U.S. Hemp Authority, an industry group responsible for the U.S. Hemp Authority Certification Program, announced the first awards of its Certification Seal Friday to companies meeting standards for ...

  • Better Buy: Medical Marijuana vs. CV Sciences
    Motley Fool4 months ago

    Better Buy: Medical Marijuana vs. CV Sciences

    Two hemp stocks. One clear winner.

  • These 3 Stocks Trounced the Top Marijuana ETFs in 2018, and Here's Why They'll Do It Again This Year
    Motley Fool5 months ago

    These 3 Stocks Trounced the Top Marijuana ETFs in 2018, and Here's Why They'll Do It Again This Year

    Repeat performances could be in store for these big marijuana winners from last year.

  • Level Brands CEO: Farm Bill Will Prompt Big Retailers to Embrace CBD Products
    IPO-Edge.com6 months ago

    Level Brands CEO: Farm Bill Will Prompt Big Retailers to Embrace CBD Products

    Martin Sumichrast, CEO of Level Brands, which Plans to Acquire cbdMD By John Jannarone With the passing of the Farm Bill Thursday, major U.S. retailers are likely to pounce on the opportunity to stock their shelves with CBD products after waiting years for such legal clarity. That’s according Level Brands CEO Martin Sumichrast, whose company […]

  • Benzinga6 months ago

    U.S. Hemp CBD Market to Triple by 2022

    The 2018 Farm Bill will restore industrial hemp to nationwide legal production for the first time since World War II, offering vast opportunities for the industry and investment in a market expected to triple in four years. With the removal of hemp from federal prohibition under the Controlled Substances Act of 1970 (CSA), the total U.S. hemp industry now looks to expand at a healthy 18.4% through a 5-year combined annual growth rate (CAGR) from 2018-2022. New Frontier Data’s Hemp Business Journal estimates that, in leading all hemp product categories, the hemp-derived CBD market will grow from a $390 million-dollar market in 2018, to a $1.3 billion market (or 3.3x) by 2022, representing a 27.2% 5-year CAGR.

  • Benzinga6 months ago

    Farm Bill Effect: Impact on U.S. and Global Hemp Markets

    Pending President Trump’s signature next week, the 2018 Farm Bill is poised to restore industrial hemp to nationwide legal production for the first time since World War II, offering vast opportunities for the industry and investment in a market expected to triple in four years. With removal of hemp from federal prohibition under the Controlled Substances Act of 1970 (CSA), the total U.S. hemp industry now looks to expand at a healthy 18.4% through a 5-year combined annual growth rate (CAGR) from 2018-2022. Hemp Business Journal estimates that, in leading all hemp product categories, the hemp-derived CBD market will grow from a $390 million-dollar market in 2018, to a $1.3 billion market (3.3x) by 2022, representing a 27.2% 5-year CAGR.

  • TheStreet.com6 months ago

    Farm Bill Passes, and These Hemp Companies Will Be Big Winners

    The 2018 Farm Bill was passed by the Senate on Tuesday by a vote of 87-13. The next move is that the legislation heads to the House for a vote -- and then if it passes there, it goes to President Trump to be signed into law. The impact of this legislation on the cannabis industry is enormous.

  • From Supermodel to Hemp? Level Brands Transforms from Kathy Ireland’s Licensing Arm to CBD Specialist
    IPO Edge7 months ago

    From Supermodel to Hemp? Level Brands Transforms from Kathy Ireland’s Licensing Arm to CBD Specialist

    Level Brands to Acquire cbdMD in All Stock Transaction   By John Jannarone Level Brands is betting the farm on hemp. The company, which went public in 2017 as a licensing vehicle for Kathy Ireland’s kathy ireland Worldwide, announced this week it would acquire Cure Based Development LLC, owner of consumer cannabidiol (CBD) brand cbdMD.  […]

  • InvestorPlace7 months ago

    Serious Questions Surround CV Sciences Stock

    CV Sciences, somewhat incredibly, has risen by a factor of 21x in just the last year. CVSI stock, in fact, has risen more than 1,000% just since April. Unlike a number of OTC marijuana-related stocks, CV Sciences has a real business.

  • Benzinga7 months ago

    The 10 Most Actively Traded OTCQX And OTCQB Stocks In October

    When the market is volatile, investors flee to safety. Often, investors will retreat out of growth names and into more established industries. We saw that trend play out in October on the over-the-counter ...

  • 7 U.S. Marijuana Stocks to Buy for the Midterm Elections
    InvestorPlace8 months ago

    7 U.S. Marijuana Stocks to Buy for the Midterm Elections

    Naturally, this has significant implications for marijuana stocks. Favorable legislation stateside and in Canada boosted marijuana stocks like Tilray (NASDAQ:TLRY) into the stratosphere. While the pain is extremely pronounced for pot stocks, I believe the political environment presents high-risk/high-reward contrarian opportunities.

  • Benzinga8 months ago

    This Is The One Cannabis Stock NOT In A Downtrend Right Now

    Nearly every publicly traded cannabis company is in a clear downtrend at the moment, as the major market indices have given back their 2018 gains. VantagePoint’s artificial intelligence and intermarket analysis signals make 1-3 day forecasts accurate up to 86 percent of the time. The chart below is a three-month chart of CVSI, where each candle represents one day of trading.

  • 5 U.S. Marijuana Stocks to Buy Before the Market Lights Up
    InvestorPlace8 months ago

    5 U.S. Marijuana Stocks to Buy Before the Market Lights Up

    One question for American investors is how that affects U.S. marijuana stocks? What happened in Canada changes little in the U.S. The federal ban on marijuana remains in place. Yes, recreational and medical marijuana are legal in nine states and 31 states respectively.

  • Investopedia8 months ago

    What Stocks are on the Marijuana Index?

    U.S. Marijuana Index, compiled by Marijuana International Corporation, has delivered 158% returns over the past one year, as of October 17, 2018. Though the market saw a lot of volatility in marijuana policy during the course of the year on account of hard line policy stance taken by the new U.